MARKET INTRODUCTION
Biologics are advanced drugs used in treatment of cancer, cardiovascular, rheumatoid arthritis, and other diseases. Biologics covers large molecules such as monoclonal antibodies, recombinant proteins and safety of these molecules ensures patient safety as these are used in the treatment of above mentioned diseases. Biologic drugs are produced from living organisms, it include recombinant proteins, tissues, genes, allergens, cells, blood components, blood, and vaccines.
MARKET DYNAMICS
Growing pharmaceutical and biotechnology industry, rising investments in research and development by key players in the life sciences industry, and rising number of new drug entering into the market are few factors driving the biologics safety testing market. However, stringent government regulations and regulatory body norms for approval of biosimilars and high cost of drug development are some factors that may restrict the market growth.
MARKET SCOPE
The "Global Biologics Safety Testing Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Biologics Safety Testing market with detailed market segmentation by product & services, application, test type and geography. The global Biologics Safety Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Biologics Safety Testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global biologics safety testing market is segmented based on product & services, test type and application. Based on product & services, the market is divided into kits & reagents, services, and instruments. Based on test type, the biologics safety testing market is segmented into endotoxin tests, sterility tests, cell line authentication and characterization tests, cell line authentication, bioburden tests, residual host contaminant detection tests, adventitious agent detection tests, and others. On the basis of application, the market is divided into vaccine development, blood products testing, cellular & gene therapy, tissue and tissue-related products testing, and stem cell research.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Biologics Safety Testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Biologics Safety Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Biologics Safety Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Biologics Safety Testing market in these regions.
MARKET PLAYERS
The reports cover key developments in the Biologics Safety Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Biologics Safety Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Biologics Safety Testing in the global market. Below mentioned is the list of few companies engaged in the Biologics Safety Testing market.
The report also includes the profiles of key Biologics Safety Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Biologics are advanced drugs used in treatment of cancer, cardiovascular, rheumatoid arthritis, and other diseases. Biologics covers large molecules such as monoclonal antibodies, recombinant proteins and safety of these molecules ensures patient safety as these are used in the treatment of above mentioned diseases. Biologic drugs are produced from living organisms, it include recombinant proteins, tissues, genes, allergens, cells, blood components, blood, and vaccines.
MARKET DYNAMICS
Growing pharmaceutical and biotechnology industry, rising investments in research and development by key players in the life sciences industry, and rising number of new drug entering into the market are few factors driving the biologics safety testing market. However, stringent government regulations and regulatory body norms for approval of biosimilars and high cost of drug development are some factors that may restrict the market growth.
MARKET SCOPE
The "Global Biologics Safety Testing Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Biologics Safety Testing market with detailed market segmentation by product & services, application, test type and geography. The global Biologics Safety Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Biologics Safety Testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global biologics safety testing market is segmented based on product & services, test type and application. Based on product & services, the market is divided into kits & reagents, services, and instruments. Based on test type, the biologics safety testing market is segmented into endotoxin tests, sterility tests, cell line authentication and characterization tests, cell line authentication, bioburden tests, residual host contaminant detection tests, adventitious agent detection tests, and others. On the basis of application, the market is divided into vaccine development, blood products testing, cellular & gene therapy, tissue and tissue-related products testing, and stem cell research.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Biologics Safety Testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Biologics Safety Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Biologics Safety Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Biologics Safety Testing market in these regions.
Biologics Safety Testing Market Report Analysis
Biologics Safety Testing Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Avance Biosciences Inc.
- Charles River Laboratories International, Inc.
- Cytovance Biologics, Inc.
- Eurofins Scientific Se
- Lonza Group Ltd.
- Merck KGaA
- SGS S. A.
- Wuxi Apptec
- Sartorius AG
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product and Services
- Kits and Reagents
- Services
- Instruments
By Test type
- Endotoxin tests
- Sterility tests
- Cell line authentication and Characterization tests
- Cell line authentication
- Bioburden tests
- Residual host contaminant detection tests
- Adventitious agent detection tests
By Application
- Vaccine development
- Blood products testing
- Cellular and gene therapy
- Tissue and tissue-related products testing
- Stem cell research
The reports cover key developments in the Biologics Safety Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Biologics Safety Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Biologics Safety Testing in the global market. Below mentioned is the list of few companies engaged in the Biologics Safety Testing market.
The report also includes the profiles of key Biologics Safety Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Avance Biosciences Inc.
- Charles River Laboratories International, Inc.
- Cytovance Biologics, Inc.
- Eurofins Scientific Se
- Lonza Group Ltd.
- Merck KGaA
- SGS S.A.
- Wuxi Apptec
- Sartorius AG
- Toxikon Corporation
- Thermo Fisher Scientific Inc.
- Pace Analytical Services Inc.
Biologics Safety Testing Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product and Services
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Medical Device : READ MORE..
The List of Companies
1. Avance Biosciences Inc.
2. Charles River Laboratories International, Inc.
3. Cytovance Biologics, Inc.
4. Eurofins Scientific Se
5. Lonza Group Ltd.
6. Merck KGaA
7. SGS S. A.
8. Wuxi Apptec
9. Sartorius AG
10. Toxikon Corporation
11. Thermo Fisher Scientific Inc.
12. Pace Analytical Services Inc.
1. Avance Biosciences Inc.
2. Charles River Laboratories International, Inc.
3. Cytovance Biologics, Inc.
4. Eurofins Scientific Se
5. Lonza Group Ltd.
6. Merck KGaA
7. SGS S. A.
8. Wuxi Apptec
9. Sartorius AG
10. Toxikon Corporation
11. Thermo Fisher Scientific Inc.
12. Pace Analytical Services Inc.